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Today, U.S. biomedical research is
caught in a painful paradox—scientific
progress is moving faster than ever. How-
ever, due to arbitrary across-the-board
spending cuts, U.S. scientific innovation
faces its greatest threat ever. Reduced
federal support for biomedical research
poses serious risks to our health and
economy, but most Americans will not
immediately feel those impacts. Who will
tell them how sequestration’s slowdown
of science imperils our nation’s future?
Scientists must sound the alarm. We
can start by highlighting how our country
is cutting research at a time when many
are doing the opposite. Between 2011
and 2012, China and India increased
spending (in constant dollars) by 20%,
South Korea and Brazil by 10%, and
Germany by 9%. In contrast, the United
States went down 5%. It seems other
nations looked at U.S. economic success
over the last 60 years and saw that our
growth came from science and tech-
nology, with biotech now leading the
way. Sadly, Americans seem to have
forgotten our own story.
What may prove to be sequestration’s
most devastating impact is the potential
loss of an entire generation of U.S.
biomedical innovation. When young
scientists survey the funding landscape,
they may question whether they have a
future here. Many may switch careers or
move to another country with stronger
scientific support. NIH is doing everything
it can to avert this dire scenario, and we
ask you to join us. Our true power lies in
the voices of scientists all across this
great nation.14 Cell 154, July 3, 2013 ª2013 Elsevier Inc.Much Deeper Than a Paper Cut
Rong Li
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Sequestration projects a 5% NIH budget
cut in 2013. Number-wise, this may not
seem substantial, but the impact is far
worse. At a recent research conference,
a most-visited topic among scientists
was how the effect of sequestration will
be felt. The anxiety of uncertainty weighs
heavily on everyone’s mind. The fear for
funding loss and need to stretch the
budget will inevitably shape a more
conservative approach to research. In an
era of fast-advancing technologies, which
often determine one’s ability to pursue
scientific inquiries at the cutting edge,
playing ‘‘Moneyball’’ is unlikely to be the
winning way.
Many lab heads are ‘‘writing grants all
the time.’’ The perception is that proposal
evaluation near the continually shrinking
funding line is like deciding between
apples and oranges. This unpredictability
of outcome is dealt with by pursuing an
approach that the more grants one
applies for, the higher likelihood of some
success of getting funded. This practice
not only drains considerable energy and
time away from productive research but
also adds burden to the grant review—
an unhelpful vicious cycle.
Frequent funding failures are having a
long-lasting effect on the careers of
many established or new scientists alike.
While young scientists stall in their career
development, established scientists—
invaluable members of a field—have also
begun to walk away from their beloved
career. These losses could amount to a
‘‘brain drain,’’ causing long-term damage
to the country’s science and technology.Short-Term Pain, Long-Term Drain
Robert Tjian
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Two pillars of U.S. science that have led to
success since Vannevar Bush (1945)—a
research culture that empowers young
scientists and an abiding national appre-
ciation for original scientific discovery—
are in peril. U.S. universities have been
the envy of the world because they
embody a culture that fosters early career
independence and stable support of
investigator-initiated science and tech-
nology research. A key to this successful
model is funding from federal and state
agencies. With sequester, the path to
scientific innovation has become more
uncertain. It is a sad reality that a first
federal research grant is now more diffi-
cult to obtain than a coveted top faculty
position. Today, most startup labs must
rely on internal university funds, primarily
from private philanthropies—an unsus-
tainable situation not seen since before
the establishment of the NIH and NSF.
Another chilling effect magnified by
sequester is the tendency, nationally and
locally, to shift funding toward applied or
clinical studies at the expense of
discovery or basic science. This trend
ignores more than 70 years of evidence
that foundational research and creation
of new frontiers are the surest path to
successful application and economic
competitiveness.
Perhaps the most damaging long-term
impact of sequester will be further
discouraging our pipeline of scientific
talent. We can and should change course
and enhance research support to restore
optimism and boost our economy, health,
and scientific culture.
Under the Spreading Atrophy
Robert Weinberg
Whitehead Institute, MIT
The research system that led to the
powerful engine of American biomedical
development is in a state of rapid implo-
sion, being deconstructed one brick at a
time with prospects for reconstruction
being remote at best. The current
sequester only adds insult to injury. The
grant system looks outwardly functional
but is actually in disarray. Few are willing
to invest serious effort in drafting applica-
tions that have far less than a 10%chance
of being funded, and peer reviewers have
lost the motivation to judge applications
whose prospects of being funded, they
know from the outset, are remote. Indeed,
quite often, economic need trumps scien-
tificquality in governing fundingdecisions.
The pipeline of innovative discovery
research, translation, and clinical treat-
ment depends on the creativity, origi-
nality, and limitless energies of young
researchers. At present, few young
trainees view careers in basic biomedical
research as realistic career options.
This crisis requires drastic response by
evaluating the large sectors of the current
NIH funding portfolio that are profoundly
unproductive yet seemingly unassailable.
Large research consortia are being
increasingly embraced, whereas the small
investigator-initiated laboratories are
quietly folding their tents, often convinced
that their failure to procure funding is their
own fault rather than the collapse of the
funding system.
I myself have had a good run. But
the American public did not invest in
my good run—they invested in future
improvements and in the young people
who have made them happen. This half-
century-long investment is being dissi-
pated. It was great while it lasted. Last
one out turn off the lights.Advocate against Sequestration
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The 2013 failure of Congress to agree
upon a deficit reduction plan resulted in
the unthinkable—an across-the-board
cut of all federally funded programs,
including domestic and defense appropri-
ations. For NIH, this 5% cut was on top of
appropriations that had declined in pur-
chasing power by 20% since 2003. NIH
agencies will reduce each grant and
fund fewer grants.
The sequester will result in the loss
of 20,000 jobs in biomedical research
(0.05 x 400,000 jobs supported by NIH
funds). Some labs may absorb a 5% cut
by economizing on supplies, but many
workers will be laid off or not replaced
when they leave a lab. Because people
do the work, the sequester will slow the
full spectrum of biomedical research.
The grim outlook for funding is dis-
couraging young people about continuing
their careers in biomedical research. It will
take years of better funding to make a
career in biomedical research appealing
again. This will hit underrepresented
groups and women particularly hard.
Biomedical research generates huge
economic and societal returns on invest-
ment, so we must be loud and clear
in explaining the shortsightedness of
sequestration. Every scientist should feel
obligated to share their own stories and
concerns with elected officials. Our com-
munity is big enough to have a huge
impact if we all act. Young people should
ask their families to weigh in as well. My
recent essay (Cell 151, 239–243) explains
how to do this.CBad for Science and the U.S.
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Automatic, arbitrary, across-the-board
budget cuts, known as the sequester,
began in March. You’ve probably heard
stories trickling out about its impacts.
From the care of cancer patients being
cut to defense contractors being laid off,
the sequester will hit every area of
government spending, including the
investments we make in our research
and education enterprise. For example,
UT Southwestern Medical Center in my
congressional district, home to world-
renowned scientists—including five
Nobel Laureates—expects around a $10
million cut in federally funded research
support.
I worry that the cuts in funding for
research will have some STEM students
reconsidering their career choices, and I
worry that cuts to STEM programs, espe-
cially those designed to bring minority
students into those fields, will make us
lose some gifted students from the pipe-
line for good. The scientists, engineers,
and innovators of today make discoveries
and develop technologies that improve
the quality of life and security of our citi-
zens, generate whole new industries and
jobs, and keep our nation thriving in a
competitive world economy. They also
help to give our children the inspiration
and grounding they will need to become
the next innovators or just to be prepared
for the high-skilled jobs of the future. Even
in these fiscally challenging times, we
must set priorities, and there are few
more important investments we can
make than in our nation’s brain power.ell 154, July 3, 2013 ª2013 Elsevier Inc. 15
